World's Best Scientists 2026 revealed!
Award Badge
Medicine
Israel
2026

D-Index & Metrics

Medicine

D-Index
110
Citations
44166
World Ranking
5569
National Ranking
12

Research.com Recognitions

  • 2026 - Research.com Medicine in Israel Leader Award
  • 2025 - Research.com Medicine in Israel Leader Award

Overview

Jacob M. Rowe is affiliated with the Israel Ministry of Health in Israel. Their research focuses primarily on the field of medicine, with significant contributions across hematology, public health, environmental and occupational health, oncology, molecular biology, and genetics.

Their main topics of research include:

  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • Childhood Cancer Survivors' Quality of Life
  • Multiple Myeloma Research and Treatments

Jacob M. Rowe has published extensively in several prominent scientific journals. Frequent publication venues include:

  • Blood
  • Haematologica
  • British Journal of Haematology
  • Leukemia & lymphoma/Leukemia and lymphoma
  • Best Practice & Research Clinical Haematology

Notable recent papers authored or co-authored by Rowe include:

  • "Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL", 2021, Blood
  • "Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network Trial", 2022, Blood
  • "Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia", 2020, Nature Cancer
  • "Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia", 2022, Blood
  • "BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study", 2020, Cancer

Frequent collaborators of Jacob M. Rowe include:

  • Selina M. Luger
  • Mark R. Litzow
  • Elisabeth Paietta
  • Martin S. Tallman
  • Charles G. Mullighan

Best Publications

  • Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

    Jay P. Patel;Mithat Gönen;Maria E. Figueroa;Hugo Fernandez

  • Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

    Marilyn L. Slovak;Kenneth J. Kopecky;Peter A. Cassileth;David H. Harrington

  • Anthracycline Dose Intensification in Acute Myeloid Leukemia

    Hugo F. Fernandez;Zhuoxin Sun;Xiaopan Yao;Mark R. Litzow

  • In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

    Anthony H. Goldstone;Susan M. Richards;Hilliard M. Lazarus;Martin S. Tallman

  • Drug therapy for acute myeloid leukemia.

    Martin S. Tallman;Martin S. Tallman;Martin S. Tallman;D. Gary Gilliland;D. Gary Gilliland;D. Gary Gilliland;Jacob M. Rowe;Jacob M. Rowe;Jacob M. Rowe

  • Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

    Adele K. Fielding;Susan M. Richards;Rajesh Chopra;Hillard M. Lazarus

  • Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

    Jacob M. Rowe;Georgina Buck;Alan Kenneth Burnett;Raj Chopra

  • Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission

    Peter A. Cassileth;David P. Harrington;Frederick R. Appelbaum;Hillard M. Lazarus

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

    Anthony V. Moorman;Christine J. Harrison;Georgina A.N. Buck;Sue M. Richards

  • All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

    Martin S. Tallman;Janet W. Andersen;Charles A. Schiffer;Frederick R. Appelbaum

  • Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia

    Panagiotis Ntziachristos;Panagiotis Ntziachristos;Aristotelis Tsirigos;Pieter Van Vlierberghe;Jelena Nedjic

  • Acute promyelocytic leukemia: evolving therapeutic strategies

    Martin S. Tallman;Chadi Nabhan;James H. Feusner;Jacob M. Rowe

  • Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.

    Bayard L. Powell;Barry Moser;Wendy Stock;Robert E. Gallagher

  • PAX5 -driven subtypes of B-progenitor acute lymphoblastic leukemia

    Zhaohui Gu;Michelle L. Churchman;Kathryn G. Roberts;Ian Moore

  • Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid

    Jae H. Park;Baozhen Qiao;Katherine S. Panageas;Maria J. Schymura

  • Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers

    Richard S. Maser;Bhudipa Choudhury;Peter J. Campbell;Bin Feng

  • The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

    Jan J. Cornelissen;Alois Gratwohl;Richard F. Schlenk;Jorge Sierra

  • T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).

    David I. Marks;Elisabeth M. Paietta;Anthony V. Moorman;Susan M. Richards

  • ECOG; MRC/NCRI Adult Leukemia Working Party. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.

    JM Rowe;G Buck;AK Burnett;R Chopra

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia

    A Moorman;C J Harrison;Buck Gan.;S M Richards

Frequent Co-Authors

Martin S. Tallman
Martin S. Tallman Northwestern University
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Mark R. Litzow
Mark R. Litzow Mayo Clinic
Anthony H. Goldstone
Anthony H. Goldstone University College Hospital
Adolfo A. Ferrando
Adolfo A. Ferrando Columbia University
Gordon W. Dewald
Gordon W. Dewald Mayo Clinic
John M. Bennett
John M. Bennett University of Rochester Medical Center
Arnon Nagler
Arnon Nagler Sheba Medical Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Medicine or a related health field in the USA, there are a variety of online degrees that can help you expand your options and gain new skills. Flexible and accredited programs make it easier to balance your studies with other responsibilities.

For those interested in health and wellness, nutrition degrees online offer science-based education in dietetics, food science, and preventive medicine. These programs can open doors to jobs in clinical dietetics, public health, or the food industry.

Aspiring healthcare leaders can pursue online mha programs designed to develop skills for management and administrative roles in hospitals, clinics, or health organizations.

Registered Nurses aiming for career advancement may find online rn to bsn programs without clinical requirements especially convenient, allowing them to earn a bachelor’s degree remotely and efficiently.

For those seeking the highest level of nursing practice, accelerated dnp programs online provide an accessible way to earn a Doctor of Nursing Practice and open up leadership or advanced clinical positions.

Best Scientists Citing Jacob M. Rowe

Trending Scientists

Recently Published Articles